Similar Articles
Paraneoplastic Rheumatic Disorders
Ömer Faruk ŞENDUR
DOI: 10.5606/tjr.2012.002
The Use of Complementary and Alternative Medicine in Turkish Patients with Rheumatic Diseases
Hasan ULUSOY, Tülün Kaya GÜÇER, Murat AKSU, Şule ARSLAN, Abdülkadir HABİBOĞLU, Gürkan AKGÖL, Ayhan BİLGİCİ, Ömer KURU, İlhan ÇETİN, Ayhan KAMANLI, Salih ÖZGÖÇMEN
DOI: 10.5606/tjr.2012.004
Diagnostic Role of Anti-Nuclear Antibodies in Rheumatic Diseases
Murat BİRTANE
DOI: 10.5606/tjr.2012.013
The Importance of Determining the Drug Agent Responsible for Pancytopenia in Patients with Rheumatoid Arthritis and Additional Systemic Diseases
Hava Üsküdar TEKE, Arzu Erdem TAŞDEMİR, Mustafa ÖZEN
DOI: 10.5606/tjr.2013.2808
The Reported Adverse Effects Related to Biological Agents Used for the Treatment of Rheumatic Diseases in Turkey
Erkan KILIÇ, Gamze KILIÇ, Özgür AKGÜL, Gürkan AKGÖL, Salih ÖZGÖÇMEN
DOI: 10.5606/tjr.2013.3052
Up-regulated Complement 3 Production by Toll-like receptor 9/ Transforming Growth Factor-Beta 1/Complement 3 Pathway in Whole Blood Cells of Lupus Thrombocytopenia
Yi YUAN, Ling ZHAO, Ning MA, Zhuang YE, Zhenyu JIANG, Congqiu CHU
DOI: 10.5606/ArchRheumatol.2017.6279
The Prevalence of Systemic Rheumatic Diseases Among Breast Cancer Patients and Its Relationship With Survival
Veli SUNAR, Öztürk ATEŞ, Alma KORCALI ASLAN, Yusuf KARAKAŞ, Mustafa Kadri ALTUNDAĞ
DOI: 10.5606/ArchRheumatol.2019.6803
Mikulicz’s Disease With Immune Thrombocytopenia: A New Immunoglobulin G4-Mediated Disorder and Literature Review
Shu LI, Cong DENG, Jinwei CHEN, Fen LI
DOI: 10.5606/ArchRheumatol.2019.7070
A Cross Sectional Study of the Impact of Human Immunodeficiency Virus, Hepatitis B Virus and Hepatitis C Virus on Rheumatoid Factor Production
Etienne Atabonkeng PHILÉMON, Christopher TUME, Marie Claire OKOMO ASSOUMOU, Salomon TCHUANDOM BONSI, Ikomey Mondide GEORGES, Hervé OUAMBO FOTSO, Lyonga EMILYA, Mesembe Tonga MARTHA, Madelaine NGANDEU-SINGWE
DOI: 10.5606/ArchRheumatol.2018.6076
A Multicenter Analysis of Subjectivity of Indirect Immunofluorescence Test in Antinuclear Antibody Screening
Vildan TURAN FARAŞAT, Talat ECEMİŞ, Yavuz DOĞAN, Aslı Gamze ŞENER, Gülfem TEREK ECE, Pınar Erbay DÜNDAR, Tamer ŞANLIDAĞ
DOI: 10.5606/ArchRheumatol.2019.7310
Sex-Based Differences in the Cytokine Production and Intracellular Signaling Pathways in Patients With Rheumatoid Arthritis
Uday P. PRATAP, Lalgi HIMA, Thangamani KANNAN, Chadrasekaran THYAGARAJAN, Hannah P. PRIYANKA, Ramasamy VASANTHAREKHA, Anand PUSHPARANI, Srinivasan THYAGARAJAN
DOI: 10.46497/ArchRheumatol.2020.7481
Outcomes and Risk Factors of Systolic Pulmonary Artery Pressure Progression in Patients with Systemic Rheumatic Diseases: Follow-up Results from a Korean Registry
Mi Ryoung SEO, Jina YEO, Hee Jung RYU, Hyo-jin CHOI, Kwang-pil KO, Han Joo BAEK
DOI: 10.46497/ArchRheumatol.2020.7812
Experience of therapeutic plasma exchange in rheumatic diseases: Albumin may be a suitable substitute for plasma
Zhiqian Bai, Yu Chen, Lingli Dong
DOI: 10.46497/ArchRheumatol.2021.8447
Clinical and laboratory characteristics of chronic spontaneous urticaria with connective tissue diseases: A cross-sectional study
Songül Çildağ, Gökhan Sargın, Taşkın Şentürk
DOI: 10.46497/ArchRheumatol.2022.8784
Thrombocytopenia in a cohort of primary and secondary antiphospholipid syndrome patients: Relation to clinical, laboratory manifestations and damage index
Sherif Gamal, Samar Mohamed, Abdelkawy Moghazy
DOI: 10.46497/ArchRheumatol.2022.9088
Vaccines in adults with autoimmune inflammatory rheumatic disease: What are the knowledge and attitudes of physicians?
Suade Özlem Badak
DOI: 10.46497/ArchRheumatol.2022.9303
Clinical course and prognostic factors of COVID-19 infection in patients with chronic inflammatory-rheumatic disease: A retrospective, case-control study
Kemal Nas, Ertuğrul Güçlü, Yaşar Keskin, Gamze Dilek, Mehtap Kalçık Unan, Nurselin Can, İbrahim Tekeoğlu, Ayhan Kamanlı
DOI: 10.46497/ArchRheumatol.2023.9289
How do COVID-19 vaccines affect rheumatic diseases?
Lale Altan, Salim Mısırcı, İlker Yağcı, Meltem Karacaatlı, Feyza Ünlü Özkan, Altuğ Güner, İlknur Aktaş
DOI: 10.46497/ArchRheumatol.2023.9530
Real-life data on the comorbidities in spondyloarthritis from our multicenter nationwide registry: BioStar
H. Fatih Çay, Meltem Alkan Melikoğlu, Fatma Gül Yurdakul, Hatice Bodur, Şebnem Ataman, Erhan Çapkın, Gülcan Gürer, İlhan Sezer, M. Tuncay Duruöz, Aylin Rezvani, İlker Yağcı, Feride Göğüş, Ayhan Kamanli, Remzi Çevik, Özgür Akgül
DOI: 10.46497/ArchRheumatol.2023.9793
Epidemiological characteristics of hepatitis B and C in patients with inflammatory arthritis: Implications from treasure database
Emine Duygu Ersözlü, Mustafa Ekici, Belkis Nihan Coşkun, Suade Özlem Badak, Emre Bilgin, Umut Kalyoncu, Burcu Yağız, Yavuz Pehlivan, Orhan Küçükşahin, Abdulsamet Erden, Dilek Solmaz, Pamir Atagündüz, Gezmiş Kimyon, Cemal Beş, Seda Çolak, Rıdvan Mercan, Timuçin Kaşifoğlu, Hakan Emmungil, Nilüfer Alpay Kanıtez, Aşkın Ateş, Süleyman Serdar Koca, Sedat Kiraz, İhsan Ertenli
DOI: 10.46497/ArchRheumatol.2023.9504